Paget-Schroetter syndrome associated with FV:Q506 and prothrombin 20210A - A case report

Angiology

Volumn 50, Issue 8, 1999, Pages 689-692

  Sayinalp, Nilgün ^a,b   Özcebe, Osman Ilhami ^a   Kirazli, Şerafettin ^a   Doǧan, Riza ^a   Dündar, Semra V ^a   Gürgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARM EXERCISE; ARTERIOVENOUS SHUNT; ARTICLE; AXILLARY VEIN; CARDIOVASCULAR RISK; CASE REPORT; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYPERCOAGULABILITY; INTRAVENOUS DRUG ADMINISTRATION; JOINT MOBILITY; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SHOULDER; SUBCLAVIAN VEIN; THROMBECTOMY; VEIN THROMBOSIS;

EID: 0032801684     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000811     Document Type: Article

References (19)

1. Aziz S, Straehley CJ, Whelan TJ: Effort related axillosubclavian vein thrombosis. Am J Surg 152:57-61, 1986.
2. Adams JT, Deweese JA: Effort thrombosis of the axillary and subclavian veins. J Trauma 11:923-930, 1971.
3. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008, 1993.
4. Bertina RM, Koeleman BPC, Koster T, et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67, 1994.
5. Voorberg J, Roelse J, Koopman R, et al: Association of idiopathic venous thromboembolism with a single point mutation at Arg506 of factor V. Lancet 343:1535-1536, 1994.
6. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis of venous thromboembolism. N Engl J Med 330:517-522, 1994.
7. Port SR, Rosendaal FR, Reitsma PH, et al: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
8. Daskalakis E, Bouhoutsos J: Subclavian and axillary vein compression of musculoskeletal origin. Br J Surg 67:573-576, 1980.
9. Lindblad B, Tengborn L, Bergqvist D: Deep vein thrombosis of the axillary-subclavian veins: Epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg 2:161-165, 1988.
10. Ochsner A, DeBakey M, DeCamp PT, et al: Thromboembolism: Analysis of cases at Charity Hospital in New Orleans over a 12-year period. Arch Surg 134:405, 1951.
11. Gürgey A, Mesci L: The prevalence of factor V Leiden mutation in Turkish population. Turk J Pediatr 39:310-315, 1997.
12. Gürgey A, Mesci L, Renda Y, et al: Factor V Leiden mutation in children with thrombosis. Am J Hematol 53:37-39, 1996.
13. Rosendaal FR, Koster T, Vandenbrouke JP, et al: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504-1508, 1995.
14. Ridker PM, Hennekens CH, Lindpaintner K, et al: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thromboembolism in apparently healthy men. N Engl J Med 332:912-917, 1995.
15. Hellgren M, Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 173:210-213, 1995.
16. Cumming AM, Keeney S, Salden A, et al: The prothrombin gene G20210A variant: Prevalence in a U.K. anticoagulant clinic population. Br J Haematol 98:353-355, 1997.
17. Ehrenforth S, Ludwing G, Klinke S, et al: The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood 91:2209-2210, 1998.
18. Zöller B, Svensson PJ, Dahlbäck B, et al. The 20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood 91:2210-2211, 1998.
19. Makris M, Preston FE, Beauchamp NJ, et al: Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 78:1426-1429, 1997.